Combining oncolytic adenovirus-mediated cytotoxic gene therapy (OAMCGT) with intensity modulated radiation therapy (IMRT) reduces the risk of having a positive prostate biopsy two years after ...
Proton therapy reduces radiation to nontargeted tissues, but for men with localized prostate cancer that may not translate to better outcomes, according to early results from the large prospective ...
SBRT is not superior to IMRT for DFS at 3 years, but it is safe and might permit better bowel quality of life. In men with favorable intermediate-risk prostate cancer, modest-dose stereotactic body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results